NCT00201539View on ClinicalTrials.gov

Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

February 29, 2008

Conditions
Cancer
Interventions
DRUG

single dose Morphine

DRUG

double dose Morphine

DRUG

placebo

purchased from the manufacturer of morphine tablets (Nycomed Pharma, Oslo, Norway)

Trial Locations (2)

7006

The Norwegian Univeristy of tecknology and science, Trondheim

St Olavs University Hospital, Trondheim

All Listed Sponsors
lead

Norwegian University of Science and Technology

OTHER

NCT00201539 - Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients | Biotech Hunter | Biotech Hunter